Πέμπτη 18 Φεβρουαρίου 2016

Pioglitazone may reduce cardiovascular events in high risk patients with prediabetes

Pioglitazone, an insulin sensitising agent, may reduce the risk of myocardial infarction (MI) and stroke after a recent transient ischaemic attack (TIA) or stroke in patients without diabetes who are...
recent?d=yIl2AUoC8zA recent?d=dnMXMwOfBR0 recent?i=_Ptoq3qQAFk:UYUm9Fh89T0:V_sGLiP recent?d=qj6IDK7rITs recent?i=_Ptoq3qQAFk:UYUm9Fh89T0:gIN9vFw recent?d=l6gmwiTKsz0 recent?d=7Q72WNTAKBA recent?i=_Ptoq3qQAFk:UYUm9Fh89T0:F7zBnMy recent?i=_Ptoq3qQAFk:UYUm9Fh89T0:-BTjWOF


from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1Q4KaPB
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις